Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis.


Journal

PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360

Informations de publication

Date de publication:
03 2021
Historique:
received: 22 06 2020
accepted: 27 01 2021
revised: 15 03 2021
pubmed: 2 3 2021
medline: 23 7 2021
entrez: 1 3 2021
Statut: epublish

Résumé

Influenza illness burden is substantial, particularly among young children, older adults, and those with underlying conditions. Initiatives are underway to develop better global estimates for influenza-associated hospitalizations and deaths. Knowledge gaps remain regarding the role of influenza viruses in severe respiratory disease and hospitalizations among adults, particularly in lower-income settings. We aggregated published data from a systematic review and unpublished data from surveillance platforms to generate global meta-analytic estimates for the proportion of acute respiratory hospitalizations associated with influenza viruses among adults. We searched 9 online databases (Medline, Embase, CINAHL, Cochrane Library, Scopus, Global Health, LILACS, WHOLIS, and CNKI; 1 January 1996-31 December 2016) to identify observational studies of influenza-associated hospitalizations in adults, and assessed eligible papers for bias using a simplified Newcastle-Ottawa scale for observational data. We applied meta-analytic proportions to global estimates of lower respiratory infections (LRIs) and hospitalizations from the Global Burden of Disease study in adults ≥20 years and by age groups (20-64 years and ≥65 years) to obtain the number of influenza-associated LRI episodes and hospitalizations for 2016. Data from 63 sources showed that influenza was associated with 14.1% (95% CI 12.1%-16.5%) of acute respiratory hospitalizations among all adults, with no significant differences by age group. The 63 data sources represent published observational studies (n = 28) and unpublished surveillance data (n = 35), from all World Health Organization regions (Africa, n = 8; Americas, n = 11; Eastern Mediterranean, n = 7; Europe, n = 8; Southeast Asia, n = 11; Western Pacific, n = 18). Data quality for published data sources was predominantly moderate or high (75%, n = 56/75). We estimate 32,126,000 (95% CI 20,484,000-46,129,000) influenza-associated LRI episodes and 5,678,000 (95% CI 3,205,000-9,432,000) LRI hospitalizations occur each year among adults. While adults <65 years contribute most influenza-associated LRI hospitalizations and episodes (3,464,000 [95% CI 1,885,000-5,978,000] LRI hospitalizations and 31,087,000 [95% CI 19,987,000-44,444,000] LRI episodes), hospitalization rates were highest in those ≥65 years (437/100,000 person-years [95% CI 265-612/100,000 person-years]). For this analysis, published articles were limited in their inclusion of stratified testing data by year and age group. Lack of information regarding influenza vaccination of the study population was also a limitation across both types of data sources. In this meta-analysis, we estimated that influenza viruses are associated with over 5 million hospitalizations worldwide per year. Inclusion of both published and unpublished findings allowed for increased power to generate stratified estimates, and improved representation from lower-income countries. Together, the available data demonstrate the importance of influenza viruses as a cause of severe disease and hospitalizations in younger and older adults worldwide.

Sections du résumé

BACKGROUND
Influenza illness burden is substantial, particularly among young children, older adults, and those with underlying conditions. Initiatives are underway to develop better global estimates for influenza-associated hospitalizations and deaths. Knowledge gaps remain regarding the role of influenza viruses in severe respiratory disease and hospitalizations among adults, particularly in lower-income settings.
METHODS AND FINDINGS
We aggregated published data from a systematic review and unpublished data from surveillance platforms to generate global meta-analytic estimates for the proportion of acute respiratory hospitalizations associated with influenza viruses among adults. We searched 9 online databases (Medline, Embase, CINAHL, Cochrane Library, Scopus, Global Health, LILACS, WHOLIS, and CNKI; 1 January 1996-31 December 2016) to identify observational studies of influenza-associated hospitalizations in adults, and assessed eligible papers for bias using a simplified Newcastle-Ottawa scale for observational data. We applied meta-analytic proportions to global estimates of lower respiratory infections (LRIs) and hospitalizations from the Global Burden of Disease study in adults ≥20 years and by age groups (20-64 years and ≥65 years) to obtain the number of influenza-associated LRI episodes and hospitalizations for 2016. Data from 63 sources showed that influenza was associated with 14.1% (95% CI 12.1%-16.5%) of acute respiratory hospitalizations among all adults, with no significant differences by age group. The 63 data sources represent published observational studies (n = 28) and unpublished surveillance data (n = 35), from all World Health Organization regions (Africa, n = 8; Americas, n = 11; Eastern Mediterranean, n = 7; Europe, n = 8; Southeast Asia, n = 11; Western Pacific, n = 18). Data quality for published data sources was predominantly moderate or high (75%, n = 56/75). We estimate 32,126,000 (95% CI 20,484,000-46,129,000) influenza-associated LRI episodes and 5,678,000 (95% CI 3,205,000-9,432,000) LRI hospitalizations occur each year among adults. While adults <65 years contribute most influenza-associated LRI hospitalizations and episodes (3,464,000 [95% CI 1,885,000-5,978,000] LRI hospitalizations and 31,087,000 [95% CI 19,987,000-44,444,000] LRI episodes), hospitalization rates were highest in those ≥65 years (437/100,000 person-years [95% CI 265-612/100,000 person-years]). For this analysis, published articles were limited in their inclusion of stratified testing data by year and age group. Lack of information regarding influenza vaccination of the study population was also a limitation across both types of data sources.
CONCLUSIONS
In this meta-analysis, we estimated that influenza viruses are associated with over 5 million hospitalizations worldwide per year. Inclusion of both published and unpublished findings allowed for increased power to generate stratified estimates, and improved representation from lower-income countries. Together, the available data demonstrate the importance of influenza viruses as a cause of severe disease and hospitalizations in younger and older adults worldwide.

Identifiants

pubmed: 33647033
doi: 10.1371/journal.pmed.1003550
pii: PMEDICINE-D-20-02925
pmc: PMC7959367
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1003550

Subventions

Organisme : Medical Research Council
ID : MC_UU_12014/9
Pays : United Kingdom

Déclaration de conflit d'intérêts

I have read the journal’s policy and the authors of this manuscript have the following competing interests: H.N.: Grants from the Foundation for Influenza Epidemiology, grants from Innovative Medicines Initiative, grants from the WHO, personal fees from Bill and Melinda Gates Foundation, grants and personal fees from Sanofi, grants from National Institute of Health Research, personal fees from Janssen and personal fees from AbbVie, outside the submitted work. The remaining authors have declared that no competing interests exist.

Références

J Infect Dis. 2013 Oct 15;208(8):1305-14
pubmed: 23863950
Vaccine. 2017 Jan 23;35(4):513-520
pubmed: 28024956
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Lancet Respir Med. 2017 Sep;5(9):738-746
pubmed: 28736045
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
Pediatrics. 2013 Feb;131(2):207-16
pubmed: 23296444
Wkly Epidemiol Rec. 2012 May 25;87(21):201-16
pubmed: 24340402
BMJ Open. 2019 Jan 17;9(1):e024687
pubmed: 30782739
Lancet Infect Dis. 2012 Jan;12(1):36-44
pubmed: 22032844
Emerg Infect Dis. 2018 Jul;24(7):1173-1177
pubmed: 29912681
JAMA. 2003 Jan 8;289(2):179-86
pubmed: 12517228
Vaccine. 2019 Aug 14;37(35):5089-5095
pubmed: 31288998
Bull World Health Organ. 2012 Apr 1;90(4):279-288B
pubmed: 22511824
Viruses. 2016 Apr 12;8(4):96
pubmed: 27077877
PLoS Med. 2016 Mar 24;13(3):e1001977
pubmed: 27011229
Lancet Respir Med. 2019 Jan;7(1):69-89
pubmed: 30553848

Auteurs

Kathryn E Lafond (KE)

Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland.

Rachael M Porter (RM)

Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Melissa J Whaley (MJ)

US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Zhou Suizan (Z)

Influenza Division, US Centers for Disease Control and Prevention, Beijing, China.

Zhang Ran (Z)

Influenza Division, US Centers for Disease Control and Prevention, Beijing, China.

Mohammad Abdul Aleem (MA)

Program for Emerging Infections, Infectious Diseases Division, icddr,b, Dhaka, Bangladesh.

Binay Thapa (B)

Royal Centre for Disease Control, Thimphu, Bhutan.

Borann Sar (B)

Centers for Disease Control and Prevention, Phnom Penh, Cambodia.

Viviana Sotomayor Proschle (VS)

Department of Epidemiology, Ministerio de Salud, Santiago, Chile.

Zhibin Peng (Z)

Division of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.

Luzhao Feng (L)

School of Population Medicine & Public Health, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China.

Daouda Coulibaly (D)

Institut National d'Hygiène Publique, Abidjan, Côte d'Ivoire.

Edith Nkwembe (E)

Institut National de Recherches Biomédicales, Kinshasa, République Démocratique du Congo.

Alfredo Olmedo (A)

Ministerio de Salud, Quito, Ecuador.

William Ampofo (W)

Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.

Siddhartha Saha (S)

Influenza Division, US Centers for Disease Control and Prevention, New Delhi, India.

Mandeep Chadha (M)

National Institute of Virology, Pune, India.

Amalya Mangiri (A)

US Centers for Disease Control and Prevention, Jakarta, Indonesia.

Vivi Setiawaty (V)

National Institute of Health Research and Development, Jakarta, Indonesia.

Sami Sheikh Ali (SS)

Ministry of Health, Amman, Jordan.

Sandra S Chaves (SS)

Influenza Division, US Centers for Disease Control and Prevention, Nairobi, Kenya.

Dinagul Otorbaeva (D)

Department of State Sanitary Epidemiological Surveillance, Bishkek, Kyrgyzstan.

Onechanh Keosavanh (O)

National Center for Laboratory and Epidemiology, Vientiane, Lao People's Democratic Republic.

Majd Saleh (M)

Epidemiological Surveillance Program, Lebanese Ministry of Public Health, Beirut, Lebanon.

Antonia Ho (A)

MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

Burmaa Alexander (B)

National Centre for Communicable Disease, Ulaanbaatar, Mongolia.

Hicham Oumzil (H)

Virology Department, Institut National d'Hygiène, Rabat, Morocco.
Faculty of Medicine, Microbiology RPU, Mohammed V University, Rabat, Morocco.

Kedar Prasad Baral (KP)

Patan Academy of Health Sciences, Lalitpur, Nepal.

Q Sue Huang (QS)

WHO National Influenza Centre, Institute of Environmental Science and Research, Wellington, New Zealand.

Adedeji A Adebayo (AA)

Nigeria Centre for Disease Control, Federal Ministry of Health, Abuja, Nigeria.

Idris Al-Abaidani (I)

Directorate General of Disease Surveillance and Control, Ministry of Health, Muscat, Oman.

Marta von Horoch (M)

Ministerio de Salud Publica y Bienestar Social, Asunción, Paraguay.

Cheryl Cohen (C)

National Institute for Communicable Diseases, Johannesburg, South Africa.

Stefano Tempia (S)

Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
MassGenics, Duluth, Georgia, United States of America.
School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Vida Mmbaga (V)

Ministry of Health, Dar es Salaam, Tanzania.

Malinee Chittaganpitch (M)

National Institute of Health, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand.

Mariana Casal (M)

Arizona Department of Health Services, Phoenix, Arizona, United States of America.

Duc Anh Dang (DA)

National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.

Paula Couto (P)

Pan American Health Organization, Washington, District of Columbia, United States of America.

Harish Nair (H)

Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.

Joseph S Bresee (JS)

Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Sonja J Olsen (SJ)

Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Eduardo Azziz-Baumgartner (E)

Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

J Pekka Nuorti (JP)

Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland.
Finnish Institute for Health and Welfare, Helsinki, Finland.

Marc-Alain Widdowson (MA)

Division of Global Health Protection, US Centers for Disease Control and Prevention, Nairobi, Kenya.
Institute of Tropical Medicine, Antwerp, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH